Bondronat 50 mg film-coated tablets
Authorisation EU/1/96/012/009-010 · Atnahs Pharma Netherlands B.V.
- Licence holder
- Atnahs Pharma Netherlands B.V. (all products →)
- Active substance
- Ibandronic acid
- Dosage form
- Film-coated tablet
- Route of administration
- Oral use
- ATC code
- M05BA06
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Full application (Article 8(3) of Directive No 2001/83/EC)
Ibandronic acid: supply and approvals
14 authorised products on the HPRA list contain Ibandronic acid. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 20 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 20 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 20 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
Centralised EU authorisation. This product holds an EU-wide marketing authorisation granted by the European Commission after assessment by the European Medicines Agency, valid in every EU country. Its EU product number is 012. The HPRA list does not say whether it is on sale.
Other medicines with Ibandronic acid in Ireland
13 other products on the HPRA list contain Ibandronic acid, from 7 licence holders; 2 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Ibandronic Acid Clonmel 150 mg film-coated tablets | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
| Ibandronic Acid Viatris 150 mg Film-coated Tablets | Viatris Limited | National authorisation (PA) | Marketed |
| Bondronat 6 mg concentrate for solution for infusion | Atnahs Pharma Netherlands B.V. | Centralised EU authorisation | Not stated |
| Bonviva 150 mg film-coated tablets | Atnahs Pharma Netherlands B.V. | Centralised EU authorisation | Not stated |
| Bonviva 3 mg solution for injection | Atnahs Pharma Netherlands B.V. | Centralised EU authorisation | Not stated |
| Iasibon 1 mg concentrate for solution for infusion | Pharmathen S.A. | Centralised EU authorisation | Not stated |
| Iasibon 2 mg concentrate for solution for infusion | Pharmathen S.A. | Centralised EU authorisation | Not stated |
| Iasibon 50 mg film-coated tablets | Pharmathen S.A. | Centralised EU authorisation | Not stated |
| Iasibon 6 mg concentrate for solution for infusion | Pharmathen S.A. | Centralised EU authorisation | Not stated |
| Ibandronic Acid Sandoz 50 mg film-coated tablets | Sandoz GmbH | Centralised EU authorisation | Not stated |
| Ibandronic Acid Teva 150 mg film-coated tablets | Teva Pharma B.V. | Centralised EU authorisation | Not stated |
| Ibandronic Acid Teva 50 mg film-coated tablets | Teva Pharma B.V. | Centralised EU authorisation | Not stated |
The licence holder
Atnahs Pharma Netherlands B.V. holds 26 products on the HPRA list, with 16 different active substances; 15 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 21 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.